收藏切换
Research on drug accessibility in national medicare negotiated
收藏切换
Zile YAN1, Qingqiang LEI1, Min HU1, 2, *
World Clinical Drug | 2025, 46(1) : 87 - 94
Less
收藏切换
World Clinical Drug | 2025, 46(1): 87-94
Research on drug accessibility in national medicare negotiated
Full
Zile YAN1, Qingqiang LEI1, Min HU1, 2, *
Affiliations
  • 1.School of Public Health, Fudan University, Shanghai 200032, China
  • 2.Yangtze River Delta Medical Security Research Center, Fudan University, Shanghai 200032, China
Published: 2025-01-10 doi: 10.13683/j.wph.2025.01.015
Outline
收藏切换
Objective

To systematically review the literature on the accessibility of national medicare negotiated drugs and summarize its improvement.

Methods

CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science were searched to collect published literature about national medicare negotiated drugs accessibility, and analyze the content of the literature.

Results

25 literatures were included, of which 17 focus on the impact of national medicare negotiated drugs accessibility, while the remaining 8 research the current status of national medicare negotiated drugs accessibility after the policy. Regarding availability, all of the literature found that the policy had a significant positive effect on the uptake of drugs, while 40%(10/25) found that there were some regional or institutional differences in the availability. Regarding affordability, only 60%(15/25) of the literature noted a sharp decrease in the price of national medicare negotiated drugs after the policy. However, 27%(4/15) mentioned that the out-of-pocket costs of most anticancer drugs were still high.

Conclusion

The National Price Negotiation policy has effectively improved drug accessibility, but it is still necessary to continuously promote the use of national medicare negotiated drugs and to improve the treatment of medicines in health insurance.

national medicare negotiated drugs  /  availability  /  affordability
晏紫乐, 雷清强, 胡敏. 国家医保谈判药品可及性的研究进展. 世界临床药物, 2025 , 46 (1) : 87 -94 . DOI: 10.13683/j.wph.2025.01.015
Zile YAN, Qingqiang LEI, Min HU. Research on drug accessibility in national medicare negotiated[J]. World Clinical Drug, 2025 , 46 (1) : 87 -94 . DOI: 10.13683/j.wph.2025.01.015
Year 2025 volume 46 Issue 1
50
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.01.015
  • Receive Date:2024-06-23
  • Online Date:2026-11-09
  • Published:2025-01-10
Article Data
Affiliations
History
  • Received:2024-06-23
  • Revised:2024-10-12
Funding
Affiliations
    1.School of Public Health, Fudan University, Shanghai 200032, China
    2.Yangtze River Delta Medical Security Research Center, Fudan University, Shanghai 200032, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.01.015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT